BioCentury
ARTICLE | Clinical News

V1512: Phase II data

September 1, 2008 7:00 AM UTC

In a Phase II pharmacokinetic study, V1512 showed an improved reproducibility and reliability of levodopa absorption compared with standard levodopa therapy. Vernalis said an upcoming Phase III trial ...